- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.01. | Pharma Equity Group A/S: Pharma Equity Group 2025 Financial Calendar | 2 | GlobeNewswire (USA) | ||
| 13.12.24 | Pharma Equity Group A/S: The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. | 56 | GlobeNewswire (Europe) | The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. December 13, 2024Announcement No. 32 Pharma Equity Group... ► Artikel lesen | |
| 29.11.24 | Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S | 1 | GlobeNewswire (USA) | ||
| 15.11.24 | Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024 | 98 | GlobeNewswire (Europe) | Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November... ► Artikel lesen | |
| 23.10.24 | Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. | 90 | GlobeNewswire (Europe) | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement... ► Artikel lesen | |
| 14.10.24 | Major shareholder announcement - Pharma Equity Group A/S | 1 | GlobeNewswire (USA) | ||
| 14.10.24 | Pharma Equity Group A/S: Managers' transactions | 1 | GlobeNewswire (USA) | ||
| PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln | |||||
| 11.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue | 295 | GlobeNewswire | The share capital of Pharma Equity Group A/S has been increased. The admittance
to trading and official listing of new shares will take effect as per 16
October 2024 in the ISIN below.
ISIN ... ► Artikel lesen | |
| 11.10.24 | Pharma Equity Group A/S: Pharma Equity Group announces successful completion of directed issue of new shares | 3 | GlobeNewswire (USA) | ||
| 04.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share | 187 | GlobeNewswire | The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024.
ISIN DK0061155009
--------------------------------------------------------------------------------
Name:... ► Artikel lesen | |
| 04.10.24 | Pharma Equity Group A/S: Pharma Equity Group announces issuance of new shares in a direct issue | 2 | GlobeNewswire (USA) | ||
| 04.10.24 | Pharma Equity Group A/S: Registration of capital reduction by way of a reduction of the nominal value and information on total share capital and number of voting rights | 1 | GlobeNewswire (USA) | ||
| 16.08.24 | Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2024 | 143 | GlobeNewswire (Europe) | Consolidated Interim Report 1 January - 30 June 2024 Company announcement no. 23 - August 16, 2024 Key points from the H1-2024 report (period 1 January - 30 June 2024) On 16 August 2024, the... ► Artikel lesen | |
| 03.06.24 | Results of extraordinary general meeting in Pharma Equity Group A/S | 179 | GlobeNewswire (Europe) | Results of extraordinary general meeting in Pharma Equity Group A/S 3 June 2024Company announcement no. 19Pharma Equity Group A/S today held an extraordinary general meeting with the following... ► Artikel lesen | |
| 16.05.24 | Pharma Equity Group A/S: Consolidated interim report 1 January - 31 March 2024 | 168 | GlobeNewswire (Europe) | Consolidated interim report 1 January - 31 March 2024 Company announcement no. 17 Date: 16 May 2024 Key points from Q1-24 report (period 1 January - 31 March 2024) On 16 May 2024, the Board of... ► Artikel lesen | |
| 05.04.24 | Pharma Equity Group A/S: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented drug candidate RNX-051. | 182 | GlobeNewswire (Europe) | 5 April 2024 Company Announcement No. 11 Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company's patented... ► Artikel lesen | |
| 22.03.24 | Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009 | 155 | GlobeNewswire (Europe) | Date: 22 March 2024 Announcement of the Year No. 9 Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009... ► Artikel lesen | |
| 20.03.24 | Pharma Equity Group A/S - Annual Report 2023 | 170 | GlobeNewswire (Europe) | Pharma Equity Group A/S - Annual Report 2023 Date: March 20, 2024Announcement of the Year No.: 7 Pharma Equity Group A/S - Annual report 2023 - main features of the year Today, the Board of Directors... ► Artikel lesen | |
| 05.03.24 | Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds | 214 | GlobeNewswire (Europe) | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ISHARES BITCOIN TRUST | 53,92 | -3,78 % | FBTC, IBIT, and ARKB ETFs analysis as Bitcoin nears key price | ||
| ALLIANZ | 321,60 | +0,44 % | Allianz Commercial mit Änderungen im Vorstand | Allianz Commercial holt Aymeric Martin, derzeit Finanzchef von Allianz Irland, in den Vorstand der Allianz Global Corporate & Specialty SE. Bei der AGCS SE als juristischer Einheit der Allianz mit Vorstandsverantwortung... ► Artikel lesen | |
| DEUTSCHE BANK | 19,668 | +0,13 % | Deutsche Bank: Konjunktur kurzgefasst | Am kommenden Sonntag findet die Wahl zum 21. Deutschen Bundestag statt. Ak-tuell ist ausweislich der Umfragen eine von CDU/CSU geführte Koalition mit der SPD und/oder den Grü-nen der wahrscheinlichste... ► Artikel lesen | |
| MUENCHENER RUECK | 518,00 | +0,58 % | BERENBERG stuft MUNICH RE auf 'Hold' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Munich Re mit einem Kursziel von 552 Euro auf "Hold" belassen. Nach den Waldbränden in Kalifornien zu Beginn des Jahres sollte... ► Artikel lesen | |
| FIDELITY WISE ORIGIN BITCOIN FUND | 82,68 | -3,92 % | Fidelity Bitcoin fund leads $103M outflow amid sideways trend | ||
| COMMERZBANK | 19,620 | +0,49 % | Commerzbank: Plus 15 Prozent - Ambitionierte Ziele | 2028 will die Commerzbank einen Gewinn von 4,2 Milliarden Euro erwirtschaften. Das teilt die Bank auf einem Kapitalmarkttag mit. Die Eigenkapitalrendite soll bei 15 Prozent liegen. Die Analysten der... ► Artikel lesen | |
| UNITED STATES NATURAL GAS FUND | 22,080 | +1,66 % | United States Natural Gas Fund, LP - 8-K, Current Report | ||
| BERKSHIRE HATHAWAY | 465,65 | +1,68 % | Alkohol und Cannabis: Constellation Brands: Greift Warren Buffett ins fallende Messer? | © Foto: Matt Rourke - picture alliance / ASSOCIATED PRESSLange Zeit dachten Anleger, Warren Buffett kennt nur noch zwei Aktien: Occidental & SiriusXM. Jetzt scheint er einen neuen Liebling entdeckt... ► Artikel lesen | |
| DEUTSCHE BOERSE | 246,90 | +0,20 % | Aktie von Deutschen Börse: Kurs mit wenig Bewegung (245,00 €) | Der Kurs der dem Anteilsschein von Deutschen Börse kommt kaum von der Stelle. Das Papier kostete zuletzt 245,00 Euro. Ein geringes Kursplus von 0,12 Prozent zeigt die Kurstafel für die Deutsche Börse-Aktie... ► Artikel lesen | |
| ARK 21SHARES BITCOIN | 94,55 | -3,81 % | Cathie Wood sells 36K shares of her own bitcoin backed ARKB to start off 2025 | ||
| GRAYSCALE ETHEREUM TRUST | 21,950 | -4,44 % | Cliftonlarsonallen Wealth Advisors LLC Invests $403,000 in Grayscale Ethereum Trust (ETH) (OTCMKTS:ETHE) | ||
| PROSHARES SHORT QQQ | 36,585 | +2,12 % | ProShares Short QQQ declares quarterly distribution of $0.6991 | ||
| BITWISE BITCOIN | 51,64 | -3,73 % | Bitwise's Bitcoin and Ethereum ETF gets initial green light from SEC | ||
| DIREXION DAILY FTSE CHINA BEAR 3X | 40,260 | -4,30 % | Direxion Daily FTSE China Bear 3X Shares declares quarterly distribution of $0.7355 | ||
| SHIFT4 PAYMENTS | 94,98 | -3,95 % | ROUNDUP/Aktien New York: Moderate Verluste - Zollunsicherheit belastet | NEW YORK (dpa-AFX) - Die auf rekordhohem Niveau notierenden US-Aktienmärkte haben am Mittwoch leicht nachgegeben. Der Leitindex Dow Jones Industrial stand gut eine halbe Stunde nach dem Start 0,34... ► Artikel lesen |
Das Unternehmen PHARMA EQUITY GROUP A/S kann der Branche Finanzdienstleistungen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMA EQUITY GROUP A/S finden Sie auf Wallstreet Online.
